caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992734172

Najamuz ZamanMD

Hematology-OncologyLancaster, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Najamuz Zaman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 19 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ROSE CITY HMA LLC1311,373
LANCASTER GENERAL HOSPITAL1181,151
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
110974
Kartik Shah
Diagnostic Radiology · Philadelphia, PA
53329
Robert Springer
Diagnostic Radiology · Lancaster, PA
47287
Naeem Latif
Medical Oncology · Lititz, PA
43477
Brian Calabrese
Hematology-Oncology · Lancaster, PA
43464
NPI 110487228230117
Masood Ahmad
Pulmonary Disease · Lancaster, PA
27310
Anthony Lacorte
Internal Medicine · Lancaster, PA
2275
Glenn Mieszkalski
Radiation Oncology · Harrisburg, PA
19471
Brian Dobslaw
Nurse Practitioner · Lancaster, PA
18137
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
454
Unique beneficiaries
—
Total services
880
Distinct HCPCS
7
Medicare payment
$63K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 417 Hematology-Oncology providers in PA — above median (cohort median 753).
PRESCRIBING · PART D · 2024
Total Rx claims
708
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
20
Brand share
39.5%
Top prescribed drugs
Apixaban90 claims
Venetoclax81 claims
Acyclovir71 claims
Anastrozole70 claims
Tamoxifen Citrate42 claims
QUALITY · MIPS · 2024
Final MIPS score
79.4
Quality
56.7
Cost
74.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.18%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$46
Payment records
2
By payment type
Food and Beverage$46